liver
First Treatment for Cerebrotendinous Xanthomatosis Approved
The FDA approved Ctexli for the lipid storage disease cerebrotendinous xanthomatosis in adults.
FEBRUARY 24, 2025
FDA Approves Hepzato Kit as a Liver-Directed Treatment for Uveal Melanoma
The FDA approved Hepzato Kit as a liver-directed treatment for adults with uveal melanoma with unresectable hepatic ...
AUGUST 17, 2023
Load more